Goldman Sachs’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Buy |
44,956
+13,699
| +44% | +$430K | ﹤0.01% | 3632 |
|
|
2025
Q1 | $927K | Sell |
31,257
-4,782
| -13% | -$142K | ﹤0.01% | 3854 |
|
|
2024
Q4 | $1.06M | Sell |
36,039
-190,302
| -84% | -$5.61M | ﹤0.01% | 3881 |
|
|
2024
Q3 | $7.05M | Buy |
226,341
+136,157
| +151% | +$4.24M | ﹤0.01% | 2518 |
|
|
2024
Q2 | $3.06M | Sell |
90,184
-6,623
| -7% | -$224K | ﹤0.01% | 2953 |
|
|
2024
Q1 | $6.29M | Buy |
96,807
+48,135
| +99% | +$3.13M | ﹤0.01% | 2395 |
|
|
2023
Q4 | $3.33M | Sell |
48,672
-26,633
| -35% | -$1.82M | ﹤0.01% | 2873 |
|
|
2023
Q3 | $3.91M | Sell |
75,305
-12,721
| -14% | -$660K | ﹤0.01% | 2652 |
|
|
2023
Q2 | $5.28M | Buy |
88,026
+47,046
| +115% | +$2.82M | ﹤0.01% | 2523 |
|
|
2023
Q1 | $2.03M | Sell |
40,980
-2,363
| -5% | -$117K | ﹤0.01% | 3204 |
|
|
2022
Q4 | $2.47M | Buy |
+43,343
| New | +$2.47M | ﹤0.01% | 3137 |
|